To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...

After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.

Pfizer reported a quarterly loss Tuesday following a large write-down, denting shares as it confirmed 2026 financial targets ...

Exciting developments in mRNA vaccines, treatments for long covid and the safe use of artificial intelligence are just some ...

Robin “Shyne” Edwards is building more than a brand; she’s cultivating a community rooted in access, visibility, and empowerment. As the founder of Noir, Edwards is reshaping how technology, ...